|
García-López R, de la Morena-Barrio ME, Alsina L, Pérez-Dueñas B, Jaeken J, Serrano M, Casado M, Hernández-Caselles T. Natural Killer Cell Receptors and Cytotoxic Activity in Phosphomannomutase 2 Deficiency (PMM2-CDG). PLoS One. 2016 Jul 14;11(7):e0158863. doi: 10.1371/journal.pone.0158863. eCollection 2016. Erratum in: PLoS One. 2016 Oct 27;11(10 ):e0165901. PubMed PMID: 27415628; PubMed Central PMCID: PMC4944953.
AÑO: 2016; IF: 2.806
|
|
Ruiz-Alcaraz AJ, Tapia-Abellán A, Fernández-Fernández MD, Tristán-Manzano M, Hernández-Caselles T, Sánchez-Velasco E, Miras-López M, Martínez-Esparza M, García-Peñarrubia P. A novel CD14(high) CD16(high) subset of peritoneal macrophages from cirrhotic patients is associated to an increased response to LPS. Mol Immunol. 2016 Apr;72:28-36. doi: 10.1016/j.molimm.2016.02.012. Epub 2016 Mar 1. PubMed PMID: 26938502.
AÑO: 2016; IF: 3.236
|
|
Lopez, RG; de la Morena-Barrio, ME; Alsina, L; Perez-Duenas, B; Jaeken, J; Serrano, M; Casado, M; Hernandez-Caselles, T. Natural Killer Cell Receptors and Cytotoxic Activity in Phosphomannomutase 2 Deficiency (PMM2-CDG) (vol 11, e0158863, 2015). PLoS One. 2016; 11(10). 10.1371/journal.pone.0165901
AÑO: 2016; IF: 2.806
|
|
García-López R, de la Morena-Barrio ME, Alsina L, Pérez-Dueñas B, Jaeken J, Serrano M, Casado M, Hernández-Caselles T. Correction: Natural Killer Cell Receptors and Cytotoxic Activity in Phosphomannomutase 2 Deficiency (PMM2-CDG). PLoS One. 2016 Oct 27;11(10):e0165901. doi: 10.1371/journal.pone.0165901. eCollection 2016. PubMed PMID: 27788260; PubMed Central PMCID: PMC5082832.
AÑO: 2016; IF: 2.806
|
|
Corral-San Miguel R, Hernández-Caselles T, Ruiz Alcaraz AJ, Martínez-Esparza M, García-Peñarrubia P. MHC-I molecules selectively inhibit cell-mediated cytotoxicity triggered by ITAM-coupled activating receptors and 2B4. PLoS One. 2014 Sep 16;9(9):e107054. doi: 10.1371/journal.pone.0107054. PubMed PMID: 25226085; PubMed Central PMCID: PMC4166474.
AÑO: 2014; IF: 3.234
|